Lyell Immunopharma, Inc. (LYEL)
15.43
+4.66
(+43.27%)
USD |
NASDAQ |
Nov 04, 16:00
15.04
-0.39
(-2.53%)
After-Hours: 07:32
Lyell Immunopharma Price : 15.43 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2026 | 12.09 | 16.73 | 12.09 | 15.43 | 1.101M |
| Nov 03, 2026 | 10.92 | 11.63 | 10.58 | 10.77 | 78055.00 |
| Nov 02, 2026 | 11.04 | 11.40 | 10.56 | 10.88 | 104063.0 |
| Oct 30, 2026 | 11.26 | 11.42 | 10.79 | 11.04 | 113259.0 |
| Oct 29, 2026 | 11.00 | 11.62 | 11.00 | 11.30 | 149218.0 |
| Oct 28, 2026 | 10.01 | 11.03 | 9.84 | 10.93 | 156808.0 |
| Oct 27, 2026 | 9.34 | 10.14 | 9.26 | 10.12 | 127907.0 |
| Oct 26, 2026 | 9.35 | 9.42 | 9.075 | 9.31 | 85217.00 |
| Oct 23, 2026 | 9.33 | 9.445 | 9.05 | 9.39 | 101637.0 |
| Oct 22, 2026 | 9.40 | 9.69 | 9.27 | 9.38 | 93161.00 |
| Oct 21, 2026 | 9.65 | 10.12 | 9.29 | 9.41 | 118319.0 |
| Oct 20, 2026 | 8.74 | 10.01 | 8.565 | 9.70 | 158618.0 |
| Oct 19, 2026 | 8.00 | 9.05 | 7.92 | 8.80 | 212916.0 |
| Oct 16, 2026 | 8.24 | 8.44 | 7.921 | 8.12 | 194964.0 |
| Oct 15, 2026 | 8.00 | 8.44 | 7.76 | 8.19 | 324990.0 |
| Oct 14, 2026 | 7.42 | 8.285 | 7.195 | 7.99 | 402239.0 |
| Oct 13, 2026 | 8.27 | 8.27 | 7.39 | 7.51 | 187175.0 |
| Oct 12, 2026 | 8.63 | 8.69 | 8.23 | 8.27 | 100395.0 |
| Oct 09, 2026 | 8.72 | 9.10 | 8.615 | 8.71 | 106807.0 |
| Oct 08, 2026 | 8.49 | 8.845 | 8.21 | 8.79 | 194718.0 |
| Oct 07, 2026 | 8.48 | 8.95 | 8.38 | 8.56 | 184671.0 |
| Oct 06, 2026 | 9.13 | 9.13 | 8.585 | 8.61 | 125040.0 |
| Oct 05, 2026 | 9.27 | 9.31 | 8.66 | 9.07 | 129452.0 |
| Oct 02, 2026 | 9.55 | 9.56 | 9.21 | 9.26 | 111390.0 |
| Oct 01, 2026 | 9.80 | 9.97 | 9.36 | 9.41 | 115248.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 61.65 |
| Oncolytics Biotech, Inc. | 0.4248 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 18.99 |
| Anixa Biosciences, Inc. | 3.28 |
Price Related Metrics
| PS Ratio | 12109.61 |
| Price to Book Value | 1.544 |
| Earnings Yield | -76.27% |
| Market Cap | 361.02M |